HBHenry R. Bourne

Henry R. Bourne

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Henry R. Bourne has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lost dollars threaten research in public academic health centers

    by Henry R. Bourne, Eric Vermillion

    Decreasing federal and state support threaten long-term sustainability of research in publicly supported academic health centers. In weathering these financial threats, research at the University of California, San Francisco (UCSF) has undergone three substantial changes: (i) institutional salary support goes preferentially to senior faculty, while the young increasingly depend on grants; (ii) private and government support for research grows apace in clinical departments, but slowly declines in basic science departments; and (iii) research is judged more on its quantity (numbers of investigators and federal and private dollars) than on its goals, achievements, or scientific quality. We propose measures to alleviate these problems. Other large public academic health centers probably confront similar issues, but—except for UCSF—such centers have not been subjected to detailed public analysis.

  • Open Access

    Alfred Gilman: Intrepid, committed scientist

    by Henry R. Bourne

    Alfred Gilman died on December 23, 2015, at age 74. With Martin Rodbell, he shared the 1994 Nobel Prize in Physiology or Medicine for discovering the first heterotrimeric guanine-nucleotide-binding (G-) protein and for elucidating the best-understood molecular mechanism for transducing signals across plasma membranes of eukaryotes. Setting a lofty standard for a generation of biomedical scientists, Gilman also served as dean of a medical school, advisor to government and industry, scientific director of a state-sponsored institute for cancer research, and editor of a leading pharmacology textbook. Alfred Gilman. Image courtesy of David Gresham (University of Texas Southwestern, Dallas, TX). Alfred Goodman Gilman was born in 1941, the year his father and Louis S. Goodman produced the first edition of the pharmacology textbook medical students called “Goodman and Gilman.” Young Alfred—born, as he confessed to friends, with a “silver scientific spoon” in his mouth—would become the only scientist ever named for a textbook (1). He majored in biochemistry at Yale, and in 1962 was invited to apply to the MD-PhD program at Case Western Reserve University School of Medicine by one of his father’s friends: Earl Sutherland, who in 1971 would earn a Nobel Prize for discovering cAMP as an intracellular second messenger for hormones. When Gilman arrived at Case, Sutherland was about to move to Vanderbilt, so the budding biochemist joined the laboratory of Ted Rall, who with Sutherland had performed key experiments that led to the cAMP discovery. With Rall, Gilman used an accurate but tedious, labor-intensive assay for cAMP to study thyroid responses to hormonal stimuli. Fresh from his MD-PhD, in 1969 Gilman began postdoctoral training in the NIH laboratory of Marshall Nirenberg, who assigned him to a group focused on development of cultured neurons. Gilman told me a fascinating story about his first paper as a postdoc. …


  • Open Access

    Is 6 Years Too Long to Get a Ph.D. in Biomedical Science?

    by Henry R. Bourne

  • Open Access

    A fair deal for PhD students and postdocs

    by Henry R Bourne

    The relentless expansion that threatens the sustainability of biomedical research in the US takes a heavy toll on young researchers.


  • Open Access

    A recipe for mediocrity and disaster, in five axioms

    by Henry R Bourne

    Biomedical research in the US will become unsustainable unless scientists and research institutions start to question certain assumptions they have long taken for granted.


  • Open Access

    The writing on the wall

    by Henry R Bourne

    The biomedical research enterprise in the US has become unsustainable and urgent action is needed to address a variety of problems, including a lack of innovation, an over-reliance on soft money for faculty salaries, the use of graduate students as a source of cheap labour, and a ‘holding tank’ full of talented postdocs with limited career opportunities.